1. Home
  2. Market Research Reports
  3. Pharmaceuticals
  4. PHM220A

Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Target Date - September 2019| Publisher - BCC Publishing| Code - PHM220A
Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Notify Me

Report Includes
  • Information on the top potential drug launches by pharma companies in 2019
  • Knowledge about drug, mechanism of action, and briefing of clinical evidences
  • Detailed information and insights on the drug Upadacitinib which is manufactured by AbbVie Inc. , Ultomiris (ravulizumab-cwvz) a humanized monoclonal antibody manufactured by Alexion Pharmaceuticals Inc. and many more
  • Insights into regulatory approvals, market scope, and analysis of pipeline molecules
  • Detailed profiles of the companies and competitors related to the industry
Get Notified when New Reports are published
CUSTOM

Need to go deeper? Custom research is proprietary, specific, and actionable.

learn more...

 

 

MEMBERSHIP

Members get access to published reports 30 days before they are available to the public.

learn more...

 

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype.

Contact
© 2019 BCC Research
Privacy Policy |Site Map|Terms & Conditions